OSEBX1,423.56+0.84%
EQNR284.60+4.20%
DNB198.35-1.15%
MOWI172.80+0.45%
Brent$71.24-0.32%
EUR/USD1.0824-0.14%
DXY104.18+0.08%
INDICATIVE · SAMPLE DATA
PNIN57

Paninvest Tbk PT

Life & Health InsuranceVerified

Paninvest Tbk PT maintains a capital structure with a debt-to-equity ratio of 6.94, indicating a significant reliance on debt financing. The company's liquidity position is assessed as medium, with free cash flow of 348.56 billion IDR and cash and equivalents of 4.28 billion IDR, but this is offset by long-term debt of 155.33 trillion IDR. The return on equity of 4.19% is below the typical industry benchmark for life and health insurers, suggesting suboptimal capital efficiency. Profitability metrics show a return on assets of 0.37%, which is well below the median for the industry, indicating that the company is not effectively leveraging its asset base to generate returns. Operating income of 24.7 billion IDR and net income of 9.37 billion IDR suggest a relatively narrow margin, which may limit the company's ability to withstand economic downturns or competitive pressures. The company's revenue is not segmented by product or geography in the available data, but the concentration of revenue in a single business line (life and health insurance) may expose it to sector-specific risks. There is no indication of geographic diversification in the provided data, which could increase vulnerability to regional economic or regulatory shifts. Looking ahead, the company's growth trajectory is not explicitly outlined in the data, but the operating income and net income figures suggest a stable, albeit modest, performance. The capital expenditure of -432.08 billion IDR indicates a reduction in capital spending, which may reflect a strategic shift or a response to financial constraints. Risk factors include a medium liquidity risk due to the company's high debt load and relatively low cash reserves. The dilution risk is assessed as low, with no significant changes in shares outstanding between basic and diluted figures. However, the negative net cash position after subtracting total debt raises concerns about the company's ability to meet long-term obligations without further financing. Recent events, including analyst estimates of last actual EPS at 78.00 IDR and revenue at 1.24 trillion IDR, suggest a stable earnings performance in the most recent reporting period. No recent filings or transcripts are provided to indicate strategic changes or operational developments.

30-day price · PNIN+30.00 (+3.9%)
Low$740.00High$835.00Close$790.00As of13 May, 00:00 UTC
Profile
CompanyPaninvest Tbk PT
TickerPNIN.JK
SectorFinancials
BusinessInsurance
Industry groupInsurance
IndustryLife & Health Insurance
AI analysis

Business. Paninvest Tbk PT operates in the life and health insurance sector, generating revenue primarily through insurance premiums and investment income from its asset base.

Classification. The company is classified under the Financials sector, specifically in the Life & Health Insurance industry, with a high confidence level of 0.92 based on verified market data.

Paninvest Tbk PT maintains a capital structure with a debt-to-equity ratio of 6.94, indicating a significant reliance on debt financing. The company's liquidity position is assessed as medium, with free cash flow of 348.56 billion IDR and cash and equivalents of 4.28 billion IDR, but this is offset by long-term debt of 155.33 trillion IDR. The return on equity of 4.19% is below the typical industry benchmark for life and health insurers, suggesting suboptimal capital efficiency. Profitability metrics show a return on assets of 0.37%, which is well below the median for the industry, indicating that the company is not effectively leveraging its asset base to generate returns. Operating income of 24.7 billion IDR and net income of 9.37 billion IDR suggest a relatively narrow margin, which may limit the company's ability to withstand economic downturns or competitive pressures. The company's revenue is not segmented by product or geography in the available data, but the concentration of revenue in a single business line (life and health insurance) may expose it to sector-specific risks. There is no indication of geographic diversification in the provided data, which could increase vulnerability to regional economic or regulatory shifts. Looking ahead, the company's growth trajectory is not explicitly outlined in the data, but the operating income and net income figures suggest a stable, albeit modest, performance. The capital expenditure of -432.08 billion IDR indicates a reduction in capital spending, which may reflect a strategic shift or a response to financial constraints. Risk factors include a medium liquidity risk due to the company's high debt load and relatively low cash reserves. The dilution risk is assessed as low, with no significant changes in shares outstanding between basic and diluted figures. However, the negative net cash position after subtracting total debt raises concerns about the company's ability to meet long-term obligations without further financing. Recent events, including analyst estimates of last actual EPS at 78.00 IDR and revenue at 1.24 trillion IDR, suggest a stable earnings performance in the most recent reporting period. No recent filings or transcripts are provided to indicate strategic changes or operational developments.
Key takeaways
  • Paninvest Tbk PT has a high debt-to-equity ratio of 6.94, indicating a heavy reliance on debt financing.
  • The company's return on equity of 4.19% is below the typical industry benchmark, suggesting suboptimal capital efficiency.
  • The company's liquidity position is medium, with free cash flow of 348.56 billion IDR but a long-term debt of 155.33 trillion IDR.
  • The company's return on assets of 0.37% is well below the median for the industry, indicating poor asset utilization.
  • The company's revenue is not segmented by product or geography, which may increase vulnerability to sector-specific risks.
  • The company's capital expenditure is negative, indicating a reduction in capital spending.
  • --
  • # RATIONALES
Financial snapshot
PeriodHA-latest
CurrencyIDR
Revenue
Gross profit
Operating income$2.47T
Net income$936.69B
R&D
SG&A
D&A
SBC
Operating cash flow$330.71B
CapEx-$432.08B
Free cash flow$3.49T
Total assets$253.37T
Total liabilities$231.00T
Total equity$22.37T
Cash & equivalents$4.28T
Long-term debt$155.33T
Valuation
Market price
Market cap
Enterprise value
P/E
Reported non-GAAP P/E
EV/Revenue
EV/Op income
EV/OCF
P/B
P/Tangible book
Tangible book$22.37T
Net cash-$151.05T
Current ratio
Debt/Equity6.9
ROA0.4%
ROE4.2%
Cash conversion35.0%
CapEx/Revenue
SBC/Revenue
Asset intensity
Dilution ratio0.0%
Risk assessment
Dilution riskLow
Liquidity riskMedium
  • Net cash is negative after subtracting total debt.
Industry benchmarks
Activity: Life & Health Insurance · cohort 15 companies
MetricPNINActivity
Op margin12.3% medp25 5.6% · p75 21.6%
Net margin2.9% medp25 0.5% · p75 10.1%
Gross margin28.2% medp25 13.4% · p75 30.5%
CapEx / revenue-2.1% medp25 -8.2% · p75 -1.2%
Debt / equity694.0%27.5% medp25 4.7% · p75 66.5%top quartile
Observations
IR observations
Last actual EPS78.00 IDR
Last actual revenue1,243,817,000,000 IDR
Source data
Underlying data the analysis-pipeline pulls and audits. Fetch timestamps + content hashes show when each source was last refreshed.
Company fundamentalsperiod financials
no public URL
2026-05-16 00:16 UTC#b070e7a3
Market quoteclose IDR 790.00 · shares 4.05B diluted
no public URL
2026-05-16 00:18 UTC#be6f15fa
Source: analysis-pipeline (hybrid)Generated: 2026-05-29 00:39 UTCJob: f1d257f1